CBD Life Sciences Expands Global Footprint with Strategic Manufacturing Partnerships in Colombia and U.S.
Key Insights
CBD Life Sciences Inc. (search) (CBDL) has secured a manufacturing partnership with Colombia-based Thallos (search), positioning the company to access the $4.9 billion Latin American CBD market with high-potency products.
The company has simultaneously established a strategic alliance with Arizona-based Jeannie in a Bottle (search), gaining access to over 100 retail locations across the United States for nationwide distribution.
These dual manufacturing agreements are expected to significantly boost CBDL's revenue streams through recurring orders while strengthening its position in the global CBD supply chain.
CBD Life Sciences Inc. (search) (OTC PINK:CBDL) has announced two significant manufacturing partnerships that position the company for substantial growth in both international and domestic CBD markets.
Colombian Partnership Targets Latin American Expansion
CBDL has secured a manufacturing agreement with Thallos (search), a prominent South American company headquartered in Colombia. Under this partnership, CBDL will handle the complete production, packaging, and labeling of high-potency CBD products exclusively for Thallos.
The product line includes 2,000mg Pain Cream Salves in Mint and Cinnamon varieties, along with a 2,000mg CBD Tincture. All manufacturing will take place at CBDL's U.S.-based facilities, allowing the company to maintain strict quality control standards.
This strategic move comes as South America's CBD market is projected to exceed $4.9 billion by 2028, with Colombia emerging as a key player in the region. The partnership addresses specific challenges faced by Colombian companies like Thallos (search), which currently struggle with U.S. tariffs and regulatory hurdles when importing CBD products.
"This partnership is a game-changer for CBDL," said Lisa Nelson, CEO of CBD Life Sciences Inc. (search) "By strategically positioning ourselves as the manufacturing engine for a growing South American brand, we're opening the door to scalable, recurring revenue and strengthening our position as a dominant force in the global CBD supply chain."
Domestic Growth Through Retail Partnership
In a parallel development, CBDL has also established a manufacturing partnership with Jeannie in a Bottle (search), an Arizona-based CBD company with a national retail footprint spanning over 100 gas stations and convenience stores across the United States.
This collaboration will see CBDL formulating and manufacturing premium CBD products exclusively for Jeannie in a Bottle (search), leveraging the latter's established consumer base and retail distribution network. The agreement is expected to generate consistent monthly reorders, creating a stable revenue pipeline for CBDL.
"This partnership is a win-win - not just for CBDL and Jeannie in a Bottle (search), but for shareholders and customers alike," Nelson explained. "We're stepping into a high-velocity retail environment with a proven brand, and bringing our own formulation and production strengths to the table. This is the kind of alignment that accelerates revenue, reputation, and results."
Strategic Implications for Growth
The dual partnerships represent a significant step in CBDL's expansion strategy, providing the company with:
-
Diversified Revenue Streams: By manufacturing for both international and domestic partners, CBDL reduces market dependency while creating multiple channels for growth.
-
Enhanced Production Efficiency: Increased manufacturing volume allows CBDL to optimize its production facilities and potentially achieve economies of scale.
-
Market Access: The partnerships provide entry points to both the rapidly growing Latin American market and the established U.S. retail sector without requiring CBDL to build its own distribution networks.
-
Brand Positioning: As a manufacturing partner for established brands, CBDL strengthens its reputation as a quality producer in the CBD industry.
Company Background
CBD Life Sciences Inc. (search) develops and distributes CBD-based wellness products through retail, e-commerce, and wholesale channels. The company has also expanded into functional mushroom products through its Mushroom Madness brand.
With these new manufacturing partnerships, CBDL appears positioned to capitalize on growing demand for CBD products across multiple markets, potentially setting the stage for significant revenue growth in 2025 and beyond.